BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38449852)

  • 1. Risk factors, prognostic factors, and nomograms for distant metastases in patients with gastroenteropancreatic neuroendocrine tumors: a population-based study.
    Li X; Fan Y; Tong J; Lou M
    Front Endocrinol (Lausanne); 2024; 15():1264952. PubMed ID: 38449852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nomogram incorporating treatment data for predicting overall survival in gastroenteropancreatic neuroendocrine tumors: a population-based cohort study.
    Wu Z; Shang G; Zhang K; Wang W; Fan M; Lin R
    Int J Surg; 2024 Apr; 110(4):2178-2186. PubMed ID: 38241384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States.
    Xu Z; Wang L; Dai S; Chen M; Li F; Sun J; Luo F
    JAMA Netw Open; 2021 Sep; 4(9):e2124750. PubMed ID: 34554237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Nomogram to Predict Individual Survival of Patients with Liver-Limited Metastases from Gastroenteropancreatic Neuroendocrine Neoplasms: A US Population-Based Cohort Analysis and Chinese Multicenter Cohort Validation Study.
    Xu G; Xiao Y; Hu H; Jin B; Wu X; Wan X; Zheng Y; Xu H; Lu X; Sang X; Ge P; Mao Y; Cai J; Zhao H; Du S
    Neuroendocrinology; 2022; 112(3):263-275. PubMed ID: 33902058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomogram individually predicts the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms.
    Fang C; Wang W; Feng X; Sun J; Zhang Y; Zeng Y; Wang J; Chen H; Cai M; Lin J; Chen M; Chen Y; Li Y; Li S; Chen J; Zhou Z
    Br J Cancer; 2017 Nov; 117(10):1544-1550. PubMed ID: 28949958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a nomogram for predicting the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms.
    Xie S; Li L; Wang X; Li L
    Medicine (Baltimore); 2021 Jan; 100(2):e24223. PubMed ID: 33466202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A New Online Dynamic Nomogram: Construction and Validation of a Predictive Model for Distant Metastasis Risk and Prognosis in Patients with Gastrointestinal Stromal Tumors.
    Wu H; Ding P; Wu J; Sun C; Guo H; Chen S; Lowe S; Yang P; Tian Y; Liu Y; Zhao Q
    J Gastrointest Surg; 2023 Jul; 27(7):1429-1444. PubMed ID: 37231240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors affecting prognosis in metachronous liver metastases from WHO classification G1 and G2 gastroenteropancreatic neuroendocrine tumors after initial R0 surgical resection.
    Lv Y; Han X; Xu XF; Ji Y; Zhou YH; Sun HC; Zhou J; Fan J; Lou WH; Huang C
    BMC Cancer; 2019 Apr; 19(1):335. PubMed ID: 30961559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using a Nomogram to Preoperatively Predict Distant Metastasis of Pancreatic Neuroendocrine Tumor in Elderly Patients.
    Li G; Bing YT; Tian ML; Yuan CH; Xiu DR
    Chin Med Sci J; 2021 Sep; 36(3):218-224. PubMed ID: 34666875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, survival, and prognostic factors for patients with gastrointestinal mixed neuroendocrine non-neuroendocrine neoplasms: a SEER population-based study.
    Xu B; Zhang F; Wu R; Peng Y; Mao Z; Tong S
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15657-15669. PubMed ID: 37656242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal Metastases from Gastroenteropancreatic Neuroendocrine Tumors: Incidence, Risk Factors and Prognosis.
    Madani A; Thomassen I; van Gestel YRBM; van der Bilt JDW; Haak HR; de Hingh IHJT; Lemmens VEPP
    Ann Surg Oncol; 2017 Aug; 24(8):2199-2205. PubMed ID: 28204963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of 320 gastroenteropancreatic neuroendocrine tumors identifies TS expression as independent biomarker for survival.
    Lee HS; Chen M; Kim JH; Kim WH; Ahn S; Maeng K; Allegra CJ; Kaye FJ; Hochwald SN; Zajac-Kaye M
    Int J Cancer; 2014 Jul; 135(1):128-37. PubMed ID: 24347111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two machine learning-based nomogram to predict risk and prognostic factors for liver metastasis from pancreatic neuroendocrine tumors: a multicenter study.
    Li J; Huang L; Liao C; Liu G; Tian Y; Chen S
    BMC Cancer; 2023 Jun; 23(1):529. PubMed ID: 37296397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prognostic nomogram in patients with distant metastasis of pancreatic neuroendocrine tumors: a population-based study.
    Cai JS; Chen HY; Lu YF; Yu RS
    Future Oncol; 2020 Jan; 16(2):4369-4379. PubMed ID: 31802701
    [No Abstract]   [Full Text] [Related]  

  • 15. Nomogram Predicts Risk and Prognostic Factors for Bone Metastasis of Pancreatic Cancer: A Population-Based Analysis.
    Zhang W; Ji L; Wang X; Zhu S; Luo J; Zhang Y; Tong Y; Feng F; Kang Y; Bi Q
    Front Endocrinol (Lausanne); 2021; 12():752176. PubMed ID: 35356148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nomograms for Predicting the Risk and Prognosis of Liver Metastases in Pancreatic Cancer: A Population-Based Analysis.
    Shi H; Li X; Chen Z; Jiang W; Dong S; He R; Zhou W
    J Pers Med; 2023 Feb; 13(3):. PubMed ID: 36983591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China.
    Fang C; Wang W; Zhang Y; Feng X; Sun J; Zeng Y; Chen Y; Li Y; Chen M; Zhou Z; Chen J
    Chin J Cancer; 2017 Jun; 36(1):51. PubMed ID: 28637502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological features and prognostic factors associated with gastroenteropancreatic mixed neuroendocrine non-neuroendocrine neoplasms in Chinese patients.
    Huang YC; Yang NN; Chen HC; Huang YL; Yan WT; Yang RX; Li N; Zhang S; Yang PP; Feng ZZ
    World J Gastroenterol; 2021 Feb; 27(7):624-640. PubMed ID: 33642833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
    Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
    BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A model for predicting the overall survival of gastroenteropancreatic neuroendocrine neoplasms after surgery.
    Feng LH; Su T; Lu Y; Ren S; Huang L; Qin X; Liao T
    Scand J Gastroenterol; 2022 May; 57(5):581-588. PubMed ID: 35001789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.